When WT p53 protein is expressed in tumors with MT p53, its movement to different cellular organelles and appropriate modifications are initiated and may explain why the tumor-suppressive effects were elevated after transfecting MT p53 breast cancer cells with WT p53 plasmids (Fig. 5F–I). The gene discussed is TP53; the disease is breast carcinoma.